The emergence of antibiotic-resistant microorganisms has heightened interest in the study of endogenous antimicrobial substances and the mechanisms regulating their expression in humans. Defensins are cysteine-rich cationic peptides isolated from several mammals, including humans, with broad-spectrum antimicrobial activity. The intestinal epithelium is a surface in continual contact with luminal contents variably laden with microbes, yet infection is uncommon. The investigator proposes that epithelial defensins, which can be grouped into two distinct structural subfamilies, designated alpha- and beta-, contribute to antimicrobial defense of the enteric mucosa. Furthermore, he proposes that there is a different strategic utilization of these two subfamilies of defensins in the small intestine and colon, in terms of structure/function, anatomical patterns of expression and types of regulation. The investigator suggests that these differences have evolved to accomplish host defense in these two very different environments. To address these hypotheses, the investigator proposes to isolate and structurally characterize the predominant defensins from human small intestinal and colonic tissues, determine their in vitro antimicrobial activity in order to relate structure and function, and use model systems of enteric defensin expression as tools to examine their expression in response to inflammatory stimuli. Epithelial defensin peptides are likely to equip mucosal surfaces with a previously unrecognized defensive capability that complements other well-defined antimicrobial defenses. Determining the strategies of defense that have evolved utilizing these antimicrobial peptides will enhance our understanding of basic host defense mechanisms and may lead to the development of useful therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI032738-08
Application #
6170145
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Ash-Shaheed, Belinda
Project Start
1993-07-01
Project End
2003-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
8
Fiscal Year
2000
Total Cost
$244,577
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Chang, Cindy; Lleo, Ana; Kananurak, Anchasa et al. (2017) Human ?-Defensin 2 in Primary Sclerosing Cholangitis. Clin Transl Gastroenterol 8:e80
Bergman, P; Roan, N R; Römling, U et al. (2016) Amyloid formation: functional friend or fearful foe? J Intern Med 280:139-52
Underwood, Mark A; Arriola, Jennifer; Gerber, Colin W et al. (2014) Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatr Res 76:326-33
Clevers, Hans C; Bevins, Charles L (2013) Paneth cells: maestros of the small intestinal crypts. Annu Rev Physiol 75:289-311
Salzman, Nita H; Bevins, Charles L (2013) Dysbiosis--a consequence of Paneth cell dysfunction. Semin Immunol 25:334-41
McSorley, Stephen J; Bevins, Charles L (2013) Paneth cells: targets of friendly fire. Nat Immunol 14:114-6
Bevins, Charles L (2013) Innate immune functions of ?-defensins in the small intestine. Dig Dis 31:299-304
Leonard, Brian C; Marks, Stanley L; Outerbridge, Catherine A et al. (2012) Activity, expression and genetic variation of canine ?-defensin 103: a multifunctional antimicrobial peptide in the skin of domestic dogs. J Innate Immun 4:248-59
Tollner, Theodore L; Bevins, Charles L; Cherr, Gary N (2012) Multifunctional glycoprotein DEFB126--a curious story of defensin-clad spermatozoa. Nat Rev Urol 9:365-75
Ma, Betty W; Bokulich, Nicholas A; Castillo, Patricia A et al. (2012) Routine habitat change: a source of unrecognized transient alteration of intestinal microbiota in laboratory mice. PLoS One 7:e47416

Showing the most recent 10 out of 63 publications